Health Condition 1: M248- Other specific joint derangements,not elsewhere classified
Conditions
Interventions
Intervention1: Suprascapular Nerve block or platelet rich plasma injection.: Either USG guided suprascapular nerve block using 2% lignocaine & 40 mg Methylprednisolone or Platelet rich plasma injectio
Sponsors
Institutional PG Thesis
Eligibility
Inclusion criteria
Inclusion criteria: 1.Pain and stiffness in one or both the shoulders for at least 4 weeks. 2.Restricted active and passive range of motion at the glenohumeral joint. 3. Patients giving voluntary consent for participation in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with chronic shoulder pain due to other causes like nerve damage or neurologic disorders. 2. Patient having any skin infection over the affected shoulder. 3. Having abrasion/lacerations over the affected shoulder. 4. History of trauma to shoulder joint. 5. Patient following shoulder surgery. 6. Allergy to Methyl prednisolone 7. Contraindications to methylprednisolone-like bleeding problems, osteoporosis etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is PRP better than SSNBTimepoint: assessment will be done on day 0, 3rd day, 1 month and at 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications will be recorded- e.g Infections, Fall in BP, Bleeding.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Alok C Agrawal
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, RAIPUR
Outcome results
None listed